PD-1 Immune Checkpoint Blockade Promotes Therapeutic Cancer Vaccine to Eradicate Lung Cancer

(1) Background: Targeting inhibitory immune checkpoint molecules has highlighted the need to find approaches enabling the activation of immune responses against cancer. Therapeutic vaccination, which induces specific immune responses against tumor antigens (Ags), is an attractive option. (2) Methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Kadam, Pournima, Sharma, Sherven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350208/
https://www.ncbi.nlm.nih.gov/pubmed/32570793
http://dx.doi.org/10.3390/vaccines8020317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350208/
https://www.ncbi.nlm.nih.gov/pubmed/32570793
http://dx.doi.org/10.3390/vaccines8020317

Ejemplares similares